Back to User profile » Prof. Dr. Xinjun Cai
Papers published by Prof. Dr. Xinjun Cai:
Intratracheal Administration of pH-Responsive Nanomicelles: A More Effective Strategy for Enhanced Intracellular Drug Delivery in Lung Cancer Treatment
Lin L, Wang G, Zhang J, Luo J, Fan X, Gao J, Cai X
International Journal of Nanomedicine 2026, 21:555824
Published Date: 10 March 2026
Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis jirovecii Pneumonia in a Critically Ill Patient with HIV/TB Coinfection: Pharmacokinetics and Clinical Outcomes
Ma X, Zhang R, Zheng R, Cheng J, Wu C, Cai X, Li J
Infection and Drug Resistance 2025, 18:5489-5497
Published Date: 25 October 2025
Simultaneous Anti-Tuberculosis and Anti-Tumor Treatment with Immune Checkpoint Inhibitors for Co-Existent Pulmonary Tuberculosis and Advanced Lung Cancer
Wang H, Gao L, Cai X, Li J, Lang Y, Zheng R, Yang S
Infection and Drug Resistance 2025, 18:107-112
Published Date: 6 January 2025
Plasma Concentrations of Contezolid and Its Efficacy and Safety in Elderly Patients with Multidrug-Resistant Tuberculosis and Renal Insufficiency
Ma X, Zhang R, Cai X, Lang Y, Wang H, Li J
Infection and Drug Resistance 2024, 17:3047-3056
Published Date: 15 July 2024
Therapeutic Drug Monitoring of Linezolid in Drug-Resistant Tuberculosis Patients: Clinical Factors and Hematological Toxicities
Cheng J, Yuan Y, Li J, Zhang R, Fan X, Xu Z, Lin H, Cai X, Zheng M
Infection and Drug Resistance 2024, 17:2531-2540
Published Date: 20 June 2024
Lessons from Multiple Infections Such as Lymphoma Complicated with Pneumocystis Infection: A Case Report
Wang H, Lang Y, Cai X, Gao L, Yang S, Jin J
Infection and Drug Resistance 2024, 17:1583-1588
Published Date: 22 April 2024
Individualized Pharmaceutical Care for Antifungal Therapy in a Patient with Aspergillus tubingensis Spondylitis After Discontinuation of Rifampicin: A Case Report
Li J, Cai X, Xu Y, Zhang R
Infection and Drug Resistance 2023, 16:4349-4356
Published Date: 4 July 2023
